Anteris Technologies Global Corp.

AVR Healthcare Medical Instruments & Supplies

Anteris Technologies Global Corp.’s revenue for fiscal 2025 (year ended December 2025) was $1.9 million, down 29.2% from fiscal 2024. In the quarter to June 2026, revenue grew 63.3%, EPS grew 48.3%, free cash flow fell 6.84% and total debt rose 8.15%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

6.05 0.31 −4.87%
Market cap
$619.8M
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
2/9
Altman Z
−31.49
Beneish M
−6.30
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
ROE
(75.13%) (59.28%) (301.60%) (757.94%)

+7 more TTM periods

ROA
(66.31%) (53.92%) (181.58%) (340.10%)
ROIC
0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
(41.77%) (34.26%) 21,592.66% (2,731.44%)
Average Days of Receivables
89.22 45.55 6.11 39.93
Free Cash Flow per Share
(0.91) (1.05) (2.16) (2.20)
Free Cash Flow
(88.27) (86.84) (79.76) (79.43)
Other line items

Show all line items

Columns are period end dates